Literature DB >> 22949722

RNAi in cultured mammalian cells using synthetic siRNAs.

Kenneth Chang, Krista Marran, Amy Valentine, Gregory J Hannon.   

Abstract

RNA interference (RNAi) enables sequence-specific, experimentally induced silencing of almost any gene by tapping into innate regulatory mechanisms that are conserved among virtually all eukaryotes. In a typical RNAi experiment, an artificial silencing trigger directs the RNAi pathway toward a target that it would not normally recognize. This is most often an endogenous protein-coding gene, although some noncoding RNAs can also be silenced effectively. The artificial silencing trigger varies; this protocol uses synthetic small interfering RNAs (siRNAs). Lipofectamine 2000 is used to deliver the siRNAs into HEK293 cells. This lipid reagent has proven to be effective for many different cultured mammalian cell lines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949722      PMCID: PMC3541682          DOI: 10.1101/pdb.prot071076

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  8 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

2.  Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.

Authors:  Jason W Myers; Joshua T Jones; Tobias Meyer; James E Ferrell
Journal:  Nat Biotechnol       Date:  2003-02-18       Impact factor: 54.908

3.  Design of a genome-wide siRNA library using an artificial neural network.

Authors:  Dieter Huesken; Joerg Lange; Craig Mickanin; Jan Weiler; Fred Asselbergs; Justin Warner; Brian Meloon; Sharon Engel; Avi Rosenberg; Dalia Cohen; Mark Labow; Mischa Reinhardt; François Natt; Jonathan Hall
Journal:  Nat Biotechnol       Date:  2005-07-17       Impact factor: 54.908

4.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

5.  The human RNA kinase hClp1 is active on 3' transfer RNA exons and short interfering RNAs.

Authors:  Stefan Weitzer; Javier Martinez
Journal:  Nature       Date:  2007-05-10       Impact factor: 49.962

Review 6.  Structure and function of the protein kinase R.

Authors:  A J Sadler; B R G Williams
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  An accurate and interpretable model for siRNA efficacy prediction.

Authors:  Jean-Philippe Vert; Nicolas Foveau; Christian Lajaunie; Yves Vandenbrouck
Journal:  BMC Bioinformatics       Date:  2006-11-30       Impact factor: 3.169

  8 in total
  8 in total

1.  Generation of transgenic Drosophila expressing shRNAs in the miR-1 backbone.

Authors:  Kenneth Chang; Krista Marran; Amy Valentine; Gregory J Hannon
Journal:  Cold Spring Harb Protoc       Date:  2014-05-01

2.  Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.

Authors:  Xiao-Yan Zou; Dong Ding; Na Zhan; Xiao-Ming Liu; Cheng Pan; Yu-Min Xia
Journal:  J Invest Dermatol       Date:  2014-09-03       Impact factor: 8.551

Review 3.  Biochemical Methods To Investigate lncRNA and the Influence of lncRNA:Protein Complexes on Chromatin.

Authors:  Emily J McFadden; Amanda E Hargrove
Journal:  Biochemistry       Date:  2016-02-24       Impact factor: 3.162

4.  Inducing RNAi in Drosophila cells by transfection with dsRNA.

Authors:  Rui Zhou; Stephanie Mohr; Gregory J Hannon; Norbert Perrimon
Journal:  Cold Spring Harb Protoc       Date:  2013-05-01

Review 5.  Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies.

Authors:  Nonthaphat Kent Wong; Chien-Ling Huang; Rashidul Islam; Shea Ping Yip
Journal:  J Hematol Oncol       Date:  2018-11-22       Impact factor: 17.388

6.  Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.

Authors:  Michael B Wolfe; Trista L Schagat; Michelle T Paulsen; Brian Magnuson; Mats Ljungman; Daeyoon Park; Chi Zhang; Zachary T Campbell; Aaron C Goldstrohm; Peter L Freddolino
Journal:  RNA       Date:  2020-08-04       Impact factor: 4.942

Review 7.  A Brief Overview of lncRNAs in Endothelial Dysfunction-Associated Diseases: From Discovery to Characterization.

Authors:  Rashidul Islam; Christopher Lai
Journal:  Epigenomes       Date:  2019-09-13

8.  Dose-dependent targeted suppression of P-glycoprotein expression and function in Caco-2 cells.

Authors:  Stephen D Lee; Jo-Ann Osei-Twum; Kishor M Wasan
Journal:  Mol Pharm       Date:  2013-05-02       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.